Skip to main content
TipRanks
Go Ultimate75% OFF

Glyn Owain Edwards Insider Profile

4 Followers

Glyn Owain Edwards, former Chief Executive Officer at Summit Therapeutics, holds 835.81K shares in Summit Therapeutics (Ticker: GB:SUMM). Most recently, Glyn Owain Edwards Bought 452,475 shares of Summit Therapeutics on Dec 06, 2019 for an estimated value of 100.00K .

Glyn Owain Edwards's Trading History

SUMM
Summit Therapeutics
Dec 06, 2019―Informative Buy100.00K£313.43K
GB:SUMM
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 06, 2019Informative Buy£100.00K452,475£22.00――
Jul 16, 2018Informative Buy£57.00K150,000£38.00-37.60%―
Jul 30, 2014Informative Buy£31.35K30,000£104.00+44.90%―
Jul 03, 2013Informative Buy£30.00K600,000£5.00――
Apr 05, 2012Informative Buy£13.96K400,000£3.00――

You May Also Like

Glyn Owain Edwards insider profile FAQ

What is the percentage of profitable transactions made by Glyn Owain Edwards?
The percentage of profitable transactions made by Glyn Owain Edwards is 50%.
What is the average return per transaction made by Glyn Owain Edwards?
The average return per transaction made by Glyn Owain Edwards is 3.60%.
What stocks does Glyn Owain Edwards hold?
Glyn Owain Edwards holds: GB:SUMM stocks.
What was Glyn Owain Edwards’s latest transaction?
Glyn Owain Edwards’s latest transaction was an Informative Buy of 100.00K .
What was Glyn Owain Edwards's most profitable transaction?
Glyn Owain Edwards’s most profitable transaction was an Informative Buy of GB:SUMM stock on July 30, 2014. The return on the trade was 44.90%.
What is Glyn Owain Edwards's role in Summit Therapeutics?
Glyn Owain Edwards's role in Summit Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.